Pathway Financial Advisors LLC Purchases Shares of 920 Oracle Corporation $ORCL

Pathway Financial Advisors LLC purchased a new stake in shares of Oracle Corporation (NYSE:ORCLFree Report) in the 2nd quarter, HoldingsChannel reports. The fund purchased 920 shares of the enterprise software provider’s stock, valued at approximately $201,000.

Several other hedge funds have also modified their holdings of ORCL. Brighton Jones LLC lifted its position in shares of Oracle by 189.3% during the fourth quarter. Brighton Jones LLC now owns 153,580 shares of the enterprise software provider’s stock valued at $25,593,000 after buying an additional 100,494 shares during the last quarter. Revolve Wealth Partners LLC lifted its position in shares of Oracle by 8.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 5,418 shares of the enterprise software provider’s stock valued at $903,000 after buying an additional 404 shares during the last quarter. GAMMA Investing LLC lifted its position in shares of Oracle by 8.1% during the first quarter. GAMMA Investing LLC now owns 34,011 shares of the enterprise software provider’s stock valued at $4,755,000 after buying an additional 2,546 shares during the last quarter. Krilogy Financial LLC acquired a new position in shares of Oracle during the first quarter valued at about $1,416,000. Finally, Wealth Enhancement Advisory Services LLC increased its holdings in shares of Oracle by 23.0% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 575,124 shares of the enterprise software provider’s stock valued at $80,408,000 after acquiring an additional 107,547 shares in the last quarter. 42.44% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts have recently issued reports on ORCL shares. Mizuho upped their price objective on shares of Oracle from $300.00 to $350.00 and gave the company an “outperform” rating in a report on Wednesday, September 10th. Redburn Partners set a $175.00 price objective on shares of Oracle in a report on Thursday, September 25th. Piper Sandler upped their price objective on shares of Oracle from $270.00 to $330.00 and gave the company an “overweight” rating in a report on Wednesday, September 10th. Baird R W upgraded shares of Oracle to a “strong-buy” rating in a report on Wednesday, October 8th. Finally, Evercore ISI upped their price objective on shares of Oracle from $340.00 to $350.00 and gave the company an “outperform” rating in a report on Friday. Three investment analysts have rated the stock with a Strong Buy rating, twenty-seven have assigned a Buy rating, nine have assigned a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $306.71.

Check Out Our Latest Research Report on Oracle

Insider Activity

In other news, Director Naomi O. Seligman sold 2,222 shares of the firm’s stock in a transaction that occurred on Friday, September 26th. The shares were sold at an average price of $288.91, for a total transaction of $641,958.02. Following the sale, the director owned 29,225 shares of the company’s stock, valued at $8,443,394.75. This trade represents a 7.07% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Clayton M. Magouyrk sold 21,241 shares of the firm’s stock in a transaction that occurred on Friday, September 12th. The stock was sold at an average price of $297.11, for a total transaction of $6,310,913.51. Following the sale, the insider directly owned 78,000 shares in the company, valued at $23,174,580. The trade was a 21.40% decrease in their position. The disclosure for this sale can be found here. Insiders sold 104,314 shares of company stock worth $31,272,223 over the last 90 days. Company insiders own 40.90% of the company’s stock.

Oracle Price Performance

Shares of NYSE:ORCL opened at $293.04 on Monday. Oracle Corporation has a twelve month low of $118.86 and a twelve month high of $345.72. The company’s 50 day moving average is $266.69 and its 200 day moving average is $210.74. The company has a current ratio of 0.62, a quick ratio of 0.62 and a debt-to-equity ratio of 3.33. The company has a market cap of $835.40 billion, a PE ratio of 67.83, a price-to-earnings-growth ratio of 3.15 and a beta of 1.53.

Oracle (NYSE:ORCLGet Free Report) last issued its quarterly earnings results on Tuesday, September 9th. The enterprise software provider reported $1.47 earnings per share for the quarter, missing the consensus estimate of $1.48 by ($0.01). The business had revenue of $14.93 billion during the quarter, compared to analyst estimates of $15.04 billion. Oracle had a return on equity of 72.93% and a net margin of 21.08%.Oracle’s quarterly revenue was up 12.2% compared to the same quarter last year. During the same quarter last year, the company posted $1.39 EPS. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. On average, sell-side analysts forecast that Oracle Corporation will post 5 EPS for the current year.

Oracle Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 23rd. Stockholders of record on Thursday, October 9th will be paid a dividend of $0.50 per share. The ex-dividend date of this dividend is Thursday, October 9th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.7%. Oracle’s dividend payout ratio (DPR) is presently 46.30%.

Oracle Profile

(Free Report)

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.

Further Reading

Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Corporation (NYSE:ORCLFree Report).

Institutional Ownership by Quarter for Oracle (NYSE:ORCL)

Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.